Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT ‐2 study-Reference-Cited by-同舟云学术

Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT ‐2 study

Published:2021-03-15 Issue:7 Volume:23 Page:1496-1504
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Araki Eiichi¹^ORCID,Mathieu Chantal²^ORCID,Shiraiwa Toshihiko³,Maeda Hajime⁴,Ikeda Hiroki⁵,Thoren Fredrik⁶,Arya Niki⁷,Asano Michiko⁸,Iqbal Nayyar⁷

Affiliation:

1. Department of Metabolic Medicine, Faculty of Life Sciences Kumamoto University Kumamoto Japan

2. Clinical and Experimental Endocrinology University of Leuven Leuven Belgium

3. Shiraiwa Medical Clinic Osaka Japan

4. H.E.C. Science Clinic Yokohama Japan

5. Ikeda Hospital Amagasaki Japan

6. Biopharmaceuticals R&D, AstraZeneca Gothenburg Sweden

7. Biopharmaceuticals R&D, AstraZeneca Gaithersburg Maryland USA

8. Research & Development, AstraZeneca K.K. Osaka Japan

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14362

Reference32 articles.

1. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth

2. Ministry of Health Labour and Welfare.Patient Survey 2014 and 2017.https://www.e-stat.go.jp/stat-search/files?page=1&toukei=00450022&tstat=000001031167. Accessed September 23 2020.

3. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus;Fullerton B;Cochrane Database Syst Rev.,2014

4. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

5. Hypoglycemia and Cardiovascular Risks

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unexpected Acute Hyperglycemia Following Pre-Surgical Discontinuation of SGLT2 Inhibitors in a Type 1 Diabetic Patient;American Journal of Case Reports;2023-05-23

2. Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients;Frontiers in Pharmacology;2023-01-04

3. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Urine Albumin to Creatinine Ratio in Type 2 Diabetes Mellitus Patients and Medication Care;Journal of Diabetes Research;2022-07-20

4. A Network Meta-Analysis of the Dose–Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes;Frontiers in Endocrinology;2022-07-07

5. Current clinical state of type 1 diabetes in Saitama prefecture;Diabetology International;2021-11-01